| Literature DB >> 22778775 |
Chung-Wah Cheng1, Annie O L Kwok, Zhao-Xiang Bian, Doris M W Tse.
Abstract
Constipation is a common problem in advanced cancer patients; however, specific clinical guidelines on traditional Chinese medicine (TCM) syndrome (Zhang) are not yet available. In this cross-sectional study, the TCM syndromes distribution and their common symptoms and signs among 225 constipated advanced cancer patients were determined. Results showed that 127 patients (56.4%) and 7 patients (3.1%) were in deficient and excessive patterns, respectively, while 91 patients (40.4%) were in deficiency-excess complex. The distributions of the five syndromes were: Qi deficiency (93.3%), Qi stagnation (40.0%), blood (Yin) deficiency (28.9%), Yang deficiency (22.2%), and excess heat (5.8%). Furthermore, age, functional status, and level of blood haemoglobin were factors related to the type of TCM syndrome. A TCM prescription with the functions on replenishing the Deficiency, redirecting the flow of Qi stagnation and moistening the dryness caused by the blood (Yin) deficiency can be made for the treatment of advance cancer patients with constipation. Robust trials are urgently needed for further justifying its efficacy and safety in evidence-based approaches.Entities:
Year: 2012 PMID: 22778775 PMCID: PMC3388626 DOI: 10.1155/2012/739642
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Patient demographic data.
| Deficiency ( | Excess ( | Complex ( |
| |
|---|---|---|---|---|
| Gender ratio male: female | 1 : 0.84 | 1 : 0.75 | 1 : 0.98 | 0.837 |
| Age in years (mean ± SD) | 75.82 ± 11.21 | 67.14 ± 9.17 | 72.57 ± 12.85 | 0.039 |
| PPS (0–100) (mean ± SD) | 55.69 ± 16.18 | 71.67 ± 17.22 | 60.23 ± 15.49 | 0.016 |
|
| ||||
| Primary cancer | Number of patients (% within group) | |||
|
| ||||
| Lung | 38 (29.9%) | 3 (42.9%) | 24 (26.4%) | 0.898 |
| Colorectal | 11 (8.7%) | 1 (14.3%) | 16 (17.6%) | |
| Hepatobiliary | 16 (12.6%) | 1 (14.3%) | 9 (9.9%) | |
| Prostate | 9 (7.1%) | 0 (0%) | 6 (6.6%) | |
| Stomach | 11 (8.7%) | 0 (0%) | 3 (3.3%) | |
| Breast | 7 (5.5%) | 0 (0%) | 5 (5.5%) | |
| Gynaecological | 7 (5.5%) | 0 (0%) | 3 (3.3%) | |
| Pancreas | 3 (2.4%) | 0 (0%) | 6 (6.6%) | |
| Urinary system | 4 (3.1%) | 1 (14.3%) | 4 (4.4%) | |
| Nasopharyngeal | 3 (2.4%) | 0 (0%) | 1 (1.1%) | |
| Thyroid | 3 (2.4%) | 0 (0%) | 1 (1.1%) | |
| Haematological | 3 (2.4%) | 0 (0%) | 1 (1.1%) | |
| Oesophagus | 2 (1.6%) | 0 (0%) | 1 (1.1%) | |
| Brain | 2 (1.6%) | 0 (0%) | 1 (1.1%) | |
| Head and neck | 2 (1.6%) | 0 (0%) | 0 (0%) | |
| Others | 3 (2.4%) | 0 (0%) | 4 (4.4%) | |
| Unknown/missing data | 3 (2.4%) | 1 (14.3%) | 6 (6.6%) | |
|
| ||||
| Biochemical parameters (mean ± SD) | ||||
|
| ||||
| Haemoglobin mg/dL | 10.20 ± 2.02 | 11.63 ± 1.33 | 11.00 ± 1.94 | 0.008 |
| Urea mmol/L | 5.90 ± 3.49 | 5.15 ± 3.54 | 7.01 ± 5.02 | 0.140 |
| Creatinine | 90.71 ± 47.19 | 70.50 ± 58.06 | 97.10 ± 62.50 | 0.425 |
| Alkaline phosphatase IU/L | 200.59 ± 256.56 | 187.67 ± 151.49 | 234.82 ± 275.38 | 0.711 |
| Alanine aminotransferase U/L | 36.08 ± 69.48 | 40.50 ± 15.98 | 88.64 ± 449.30 | 0.445 |
| Serum calcium mmol/L | 2.26 ± 0.27 | 2.15 ± 0.25 | 2.22 ± 0.17 | 0.243 |
| Serum albumin mg/L | 26.74 ± 6.27 | 23.00 | 27.44 ± 6.46 | 0.712 |
Deficiency: deficient pattern; excess: excessive pattern; complex: deficiency-excess complex.
PPS: palliative performance scale.
Biochemical parameters were determined for those patients with blood tests within three months.
Dominant symptoms and signs of the five syndromes.
| Excessive pattern: | |
| Excess heat: 13 patients (5.8%) | |
| Dry mouth 12/13 (92.3%), fatigue 10/13 (76.9%), phlegm production 7/13 (53.8%), slimy fur 8/13 (61.5%), white fur 8/13 (61.5%), fine pulse 7/13 (53.8%), and string-like pulse 9/13 (69.2%) | |
|
| |
|
| |
| Dry mouth 69/90 (76.7%), fatigue 81/90 (90.0%), mind disquieted/susceptible to fright 49/90 (54.4%), belching/nausea/vomiting | |
| 61/90 (67.8%), abdominal distension/pain 58/90 (64.4%), anorexia 46/90 (51.1%), inadequate pushing force 56/90 (62.2%), pale red tongue 51/90 (56.7%), white fur 60/90 (66.7%), fine pulse 64/90 (71.1%), and string-like pulse 47/90 (52.2%) | |
|
| |
| Deficient patterns: | |
|
| |
| Dry mouth 148/210 (70.5%), fatigue 200/210 (95.2%), mind disquieted/susceptible to fright 114/210 (54.3%), inadequate pushing force 110/210 (52.4%), pale red tongue 116/210 (55.2%), white fur 139/210 (66.2%), and fine pulse 147/210 (70.0%) | |
|
| |
| Blood ( | |
| Dry mouth 57/65 (87.7%), fatigue 62/65 (95.4%), mind disquieted/susceptible to fright 45/65 (69.2%), anorexia | |
| 43/65 (66.2%), inadequate pushing force 38/65 (58.5%), red tongue 51/65 (78.5%), scanty fur/peeling fur/peeled fur 48/65(73.8%), and fine pulse 45/65 (69.2%) | |
|
| |
|
| |
| Dry mouth 39/50 (78.0%), fatigue 48/50 (96%), mind disquieted/susceptible to fright 32/50 (64.0%), cold intolerance 41/50 (82.0%), pale red tongue 25/50 (50%), white fur 29/50 (58.0%), and fine pulse 33/50 (66.0%) | |
Dominant symptoms and signs were defined as prevalent for more than or equal to 50% of each syndrome.
The combination of deficiency of Qi with other syndromes.
| Patients with | Number of patients (%) |
|---|---|
|
| 70/210 (33.3%) |
| Coexistence with | |
|
| 39/210 (18.6%) |
| Blood ( | 31/210 (14.8%) |
|
| 18/210 (8.6%) |
| Excess heat | 5/210 (2.4%) |
|
| 16/210 (7.6%) |
|
| 14/210 (6.7%) |
|
| 4/210 (1.9%) |
| Deficiency of blood ( | 6/210 (2.9%) |
|
| 6/210 (2.9%) |
|
| 1/210 (0.5%) |
Prevalence of symptoms and signs among three patterns.
| Deficiency ( | Excess ( | Complex ( |
| |
|---|---|---|---|---|
| Pale/sallow complexion | 59 (46.5%) | 0 (0%) | 28 (30.8%) | 0.007 |
| Bitter taste | 28 (22.0%) | 2 (28.6%) | 37 (40.7%) | 0.012 |
| Fatigue | 122 (96.1%) | 4 (57.1%) | 82 (90.1%) | <0.001 |
| Mind disquieted/susceptible to fright | 66 (52.0%) | 0 (0%) | 50 (54.9%) | 0.019 |
| Belching/nausea/vomiting | 18 (14.2%) | 4 (57.1%) | 57 (62.6%) | <0.001 |
| Stuffiness and fullness of chest | 5 (3.9%) | 1 (14.3%) | 40 (44.0%) | <0.001 |
| Abdominal distension/pain | 9 (7.1%) | 1 (14.3%) | 57 (62.6%) | <0.001 |
| Water retention (with pleural/abdominal fluid) | 0 (0%) | 1 (14.3%) | 13 (14.3%) | <0.001 |
| Anorexia | 47 (37.0%) | 1 (14.3%) | 46 (50.5%) | 0.044 |
| Insomnia | 36 (28.3%) | 4 (57.1%) | 40 (44.0%) | 0.029 |
| Vacuous pulse | 9 (7.1%) | 3 (42.9%) | 5 (5.5%) | 0.001 |
|
| ||||
| Description of constipation symptoms | ||||
|
| ||||
| Inadequate pushing force during defecation | 54 (42.5%) | 1 (14.3%) | 58 (63.7%) | 0.001 |
| Incomplete defecation | 20 (15.7%) | 0 (0%) | 27 (29.7%) | 0.017 |
| Difficult defecation | 31 (24.4%) | 1 (14.3%) | 37 (40.7%) | 0.024 |
Deficiency: deficient pattern; excess: excessive pattern; complex: deficiency-excess complex.
Only the symptoms and signs with significant differences among three syndrome patterns were listed in the table.
The relationship between severity of constipation and opioids intake with the pattern distribution.
| Deficiency ( | Excess ( | Complex ( |
| |
|---|---|---|---|---|
| Severity (mean ± SD) | 3.19 ± 1.85 | 3.29 ± 2.21 | 3.91 ± 1.57 | 0.012 |
| No constipation | 32 (25.2%) | 3 (42.9%) | 9 (9.9%) | 0.013 |
| Constipation | 63 (49.6%) | 1 (14.35%) | 50 (54.9%) | |
| Severe constipation | 32 (25.2%) | 3 (42.9%) | 32 (35.2%) | |
| With opioids | 73 (57.5%) | 4 (57.1%) | 60 (65.9%) | 0.442 |
| With strong opioids | 29 (22.8%) | 2 (28.6%) | 26 (28.6%) | 0.618 |
| With weak opioids | 49 (38.6%) | 2 (28.6%) | 36 (39.6%) | 0.847 |
Deficiency: deficient pattern; excess: excessive pattern; complex: deficiency-excess complex.
Severity of constipation was evaluated with an 8-point ordinal rating scale, where 0-1 indicated no constipation, 2–4 indicated constipation, and 5–7 indicated severe constipation.
Strong opioids included morphine, methadone, and fentanyl, while weak opioids included tramadol, dihydrocodeine, dextropropoxyphene, and codeine.